The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for SK Kim


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase.EBI
Chungnam National University
In vitro induction of apoptosis by isosclerone from marine-derived fungus Aspergillus fumigatus.EBI
Pukyong National University
Cathepsin B inhibitory activities of phthalates isolated from a marine Pseudomonas strain.EBI
Pukyong National University
Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Design and synthesis of 3'-ureidoadenosine-5'-uronamides: effects of the 3'-ureido group on binding to the A3 adenosine receptor.EBI
Ewha Womans University
Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.EBI
Niddk
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2.EBI
Wyeth Research
Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor.EBI
Gwangju Institute of Science and Technology (GIST)
Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like Receptor 1 Antagonists for the Treatment of Psoriasis.EBI
Gwangju Institute of Science and Technology (GIST)
2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.EBI
Ghent University
Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
C-Methylated Flavonoids from Cleistocalyx operculatus and Their Inhibitory Effects on Novel Influenza A (H1N1) Neuraminidase.EBI
Chosun University
Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava.EBI
Pukyong National University
Distinct structural changes in a G protein-coupled receptor caused by different classes of agonist ligands.EBI
Niddk
Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease.EBI
Korea Institute of Science and Technology
Substituted pyridinyl-pyrimidines and their use as medicamentsBDB
Boehringer Ingelheim International
Substituted dipyridyl-dihydropyrazolones and use thereofBDB
Bayer Intellectual Property
Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.BDB
Rheinische Friedrich-Wilhelms-Universitat Bonn